National Translational Research Group — Port Jefferson Station, New York

National Translational Research Group is a clinical research site located in Port Jefferson Station, New York, United States 11776.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

National Translational Research Group has participated in 2 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC), Metastatic Non-Small Cell Lung Carcinoma.

Sponsors: Genentech, Inc., Cadex Genomics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Port Jefferson Station

Browse all research sites in New York · View every site in Port Jefferson Station

• New York Cancer and Blood Specialists
• North Suffolk Neurology
• North Suffolk Neurology, PC
• True North Neurology
• New York Cancer & Blood Specialists - Port Jefferson Medical Oncology
• New york cancer and blood specialists - Oncology
• North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists
• New York Cancer & Blood Specialists - Port Jeffers
• New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy
• New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1)
• North Shore Hematology Oncology Associates DBA NY Cancer and Blood Specialists

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for National Translational Research Group?

National Translational Research Group has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has National Translational Research Group conducted?

National Translational Research Group has 2 clinical trials on record. Their work covers Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC), Metastatic Non-Small Cell Lung Carcinoma.

Is National Translational Research Group accredited by Crixeo Clinical Trials?

National Translational Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about National Translational Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.